MENU
BBNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Beta Bionics (BBNX) Ownership - Who owns Beta Bionics?
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease... Show more
Details
Group
Domestic Stock Funds
Category
Health Services
Capitalization
640.75M
P/E Ratio
N/A
Total Cash
249.72M
Projected Growth
N/A
Total Debt
6.69M
Revenue
78.02M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.74
Total Debt/Equity
N/A
Revenue/Share
1.79 USD as % of share price
Fundamentals
BBNX
Capitalization
641M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
250M
Total Cash/Share
5.74
Total Debt
6.69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.79%
Revenue
78M
ROE
N/A
Book Value
302M
P/B Ratio
2.12
Cash Flow
N/A
Earnings
-1.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
14.68
Current Revenue Per Employee
59280.61
Dividends Per Share - Security
N/A
EBITDA
-60.13M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.80
Revenue To Assets
-22.23
Shares Held By Institutions
580M
Shares Outstanding - Current
43.5M
Total Liabilities
28.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BBNX showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information